Both in Biotechnology
Black Diamond Therapeutics vs Humacyte
Over the past year BDTX returned −54.3% and HUMA returned −73.2%; their daily moves had a correlation of 0.20.
BDTX −54.3% HUMA −73.2%Growth of $1, one year, split-adjusted
| Metric | BDTX | HUMA |
|---|---|---|
| Price | $1.81 | $0.4260 |
| Market cap | $103.7M | $118.3M |
| Today | +3.14% | +7.01% |
| 1 month | −7.0% | −14.8% |
| 6 months | −37.1% | −52.8% |
| Year to date | −25.7% | −55.6% |
| 1 year | −53.4% | −74.5% |
| Revenue growth (YoY) | — | +34.9% |
| Gross margin | — | −203.2% |
| Net margin | — | −9064.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 55.8× |
| Net cash | $110.5M | $13.7M |
| Dividend yield | — | — |
| Volatility (60d) | 61.4% | 106.8% |
| Short % of float | 11.8% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).